High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals
- PMID: 37743017
- DOI: 10.1016/j.hjc.2023.09.011
High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals
Abstract
Troponin I and T as cardiac-specific biomarkers are highly useful tools not only in the diagnosis of acute coronary syndromes but also as independent predictors of several other clinical conditions. High-sensitivity cardiac troponin (hs-cTn) assays allow the detection of considerably low concentrations of cardiac troponin in apparently healthy and asymptomatic individuals, being a candidate tool for cardiovascular risk stratification in the general population. A group of Greek experts summarized the bulk of evidence regarding the use of hs-cTnI as a predictor of cardiovascular events and mortality in apparently healthy individuals and its additive value on top of existing risk stratification methods. This document could serve as a guide for the incorporation of hs-cTnI as an additional risk stratification tool in cardiovascular prevention strategies in apparently healthy individuals.
Keywords: cardiovascular risk; general population; high-sensitivity cardiac troponin I; risk stratification; troponin.
Copyright © 2024. Published by Elsevier Inc.
Conflict of interest statement
Conflict of interest DF reports speaker honoraria from Abbott Laboratories and Roche Diagnostics.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials